PLUS Diagnostics is Laboratory Services (Healthcare) in United States that focus on breast pathology areas business. Founded in 1990. They cover business area such as Provider, diagnostic pathology service, doctor, clinician, extensive diagnostic procedure, specialist consultation, genitourinary, dermatology, gynecologic, cytopathology, hemato, breast pathology area, hospital, medical center, physician, dentist.
Laboratory Services (Healthcare)
1990
( 34 years old in 2024 )
Breast Pathology Areas
-
825 Rahway Avenue
Union, NJ 07083
United States
Private
Providerdiagnostic pathology servicedoctorclinicianextensive diagnostic procedurespecialist consultationgenitourinarydermatologygynecologiccytopathologyhematobreast pathology areahospitalmedical centerphysiciandentist
* We use standard office opening hours in near PLUS Diagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PLUS Diagnostics is Laboratory Services (Healthcare) business from United States that founded in 1990 (34 years old in 2024), PLUS Diagnostics business is focusing on Breast Pathology Areas.
PLUS Diagnostics headquarter office and corporate office address is located in 825 Rahway Avenue Union, NJ 07083 United States.
PLUS Diagnostics was founded in United States.
In 2024, PLUS Diagnostics is currently focus on breast pathology areas sector.
Above is snippet of Google Trends for "breast pathology areas" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PLUS Diagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
